Phase 2 Osteoarthritis Trial, Recruiting NCT06859164 Sponsor: University of Chicago Condition: Osteoarthritis
Back to Osteoarthritis

Phase 2 Osteoarthritis Trial, Recruiting

NCT06859164
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 40 and 80 years old
  • You have knee pain in one or both knees that has been diagnosed as osteoarthritis
  • Your knee X-rays (taken while standing) show a moderate to severe level of osteoarthritis (Grade 2–4 on a standard medical scale)
  • You have had knee pain for more than 6 months, it has not improved enough with other treatments (such as physical therapy, pain medications, bracing, or injections), and your pain scores at least a 4 out of 10
  • You prefer not to have a steroid injection into your knee joint

Who may not be able to join:

  • You currently have cancer
  • You currently have an active infection in the knee being treated
  • You have had a steroid injection in the affected knee within the last 3 months
  • You have rheumatoid arthritis or a similar inflammatory joint condition
  • You have had previous surgery on the affected knee (such as ligament repair, knee replacement, or cartilage procedures), except for a simple diagnostic procedure
  • Your knee X-rays show very mild or no osteoarthritis (Grade 0–1)
  • You are pregnant or planning to become pregnant
  • Your kidneys are not functioning well enough (confirm with trial site)
  • You have had a severe allergic reaction to iodine-based dye used in medical imaging
  • You have moderate to severe pain (above 4 out of 10) in your hip or ankle on the same side as the knee being treated
  • You weigh more than 400 lbs, as this may make the procedure unsafe
  • You have significant circulation problems in the leg being treated
  • You have Type 1 diabetes
  • You have used long-acting steroid medications within the last 6 months, or short-acting steroids within the last 3 months
  • You have a history of acute kidney injury
  • You have a history of reactions to imaging dye, asthma, or allergic conditions
  • You have had a severe allergic reaction to a specific type of MRI contrast dye (gadolinium-based)
  • You have widespread, ongoing pain scoring above 4 out of 10, including nerve-related pain
  • You have been diagnosed with major depression within the last 2 years
  • You have another serious mental health condition, such as schizophrenia or bipolar disorder
  • You have had a suicide attempt or suicidal behaviour within the last 30 days
  • You have been diagnosed with fibromyalgia
  • You are planning to have a total knee replacement within the next year
  • You have any other condition or circumstance that the trial team believes could affect your safety or ability to follow the trial procedures (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Osman Ahmed, MD, University of Chicago Department of Radiology

Phone: 8478124513

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Registry
ClinicalTrials.gov
Start date
1 May 2025
Est. completion
31 August 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Reduction in KOOS pain subscore

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov